Smit EF - Search Results

1

Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations.

Paik PK, Felip E, Veillon R, Sakai H, Cortot AB, Garassino MC, Mazieres J, Viteri S, Senellart H, Van Meerbeeck J, Raskin J, Reinmuth N, Conte P, Kowalski D, Cho BC, Patel JD, Horn L, Griesinger F, Han JY, Kim YC, Chang GC, Tsai CL, Yang JC, Chen YM, Smit EF, van der Wekken AJ, Kato T, Juraeva D, Stroh C, Bruns R, Straub J, Johne A, Scheele J, Heymach JV, Le X. Paik PK, et al. Among authors: smit ef. N Engl J Med. 2020 Sep 3;383(10):931-943. doi: 10.1056/NEJMoa2004407. Epub 2020 May 29. N Engl J Med. 2020. PMID: 32469185 Free PMC article. Clinical Trial.

2

A phase II study of high dose epirubicin in unresectable non small cell lung cancer.

Smit EF, Berendsen HH, Piers DA, Smeets J, Riva A, Postmus PE. Smit EF, et al. Br J Cancer. 1992 Mar;65(3):405-8. doi: 10.1038/bjc.1992.82. Br J Cancer. 1992. PMID: 1313691 Free PMC article. Clinical Trial.

3

Treatment of brain metastases of small cell lung cancer with teniposide.

Postmus PE, Smit EF, Berendsen HH, Sleijfer DT, Haaxma-Reiche H. Postmus PE, et al. Among authors: smit ef. Semin Oncol. 1992 Apr;19(2 Suppl 6):89-94. Semin Oncol. 1992. PMID: 1329230

4

Phase II study of high-dose epirubicin and etoposide in advanced non-small cell lung cancer.

Smit EF, Piers DA, Postmus PE. Smit EF, et al. Eur J Cancer. 1992;28A(12):1965-7. doi: 10.1016/0959-8049(92)90238-w. Eur J Cancer. 1992. PMID: 1329882 Clinical Trial.

5

A feasibility study of testing new drugs for small-cell lung cancer in patients with a poor performance status.

Postmus PE, Smit EF, Berendsen HH, Sleyfer DT. Postmus PE, et al. Among authors: smit ef. Cancer Chemother Pharmacol. 1991;27(6):490-1. doi: 10.1007/BF00685167. Cancer Chemother Pharmacol. 1991. PMID: 1849466

6

A phase II study of oral etoposide in elderly patients with small cell lung cancer.

Smit EF, Carney DN, Harford P, Sleijfer DT, Postmus PE. Smit EF, et al. Thorax. 1989 Aug;44(8):631-3. doi: 10.1136/thx.44.8.631. Thorax. 1989. PMID: 2477908 Free PMC article.

7

A phase II study of carboplatin and vincristine in previously treated patients with small-cell lung cancer.

Smit EF, Berendsen HH, de Vries EG, Mulder NH, Postmus PE. Smit EF, et al. Cancer Chemother Pharmacol. 1989;25(3):202-4. doi: 10.1007/BF00689583. Cancer Chemother Pharmacol. 1989. PMID: 2557171

8

Carboplatin as second line treatment for recurrent or progressive brain metastases from small cell lung cancer.

Groen HJ, Smit EF, Haaxma-Reiche H, Postmus PE. Groen HJ, et al. Among authors: smit ef. Eur J Cancer. 1993;29A(12):1696-9. doi: 10.1016/0959-8049(93)90107-q. Eur J Cancer. 1993. PMID: 7691116

9

Phase I study of high-dose epirubicin and vinorelbine in previously untreated non-small-cell lung cancer stage IIIB-IV.

Bakker M, Groen HJ, Smit EF, Smeets J, Riggi M, Postmus PE. Bakker M, et al. Among authors: smit ef. Br J Cancer. 1995 Dec;72(6):1547-50. doi: 10.1038/bjc.1995.545. Br J Cancer. 1995. PMID: 8519675 Free PMC article. Clinical Trial.

10

A phase II study of paclitaxel in heavily pretreated patients with small-cell lung cancer.

Smit EF, Fokkema E, Biesma B, Groen HJ, Snoek W, Postmus PE. Smit EF, et al. Br J Cancer. 1998;77(2):347-51. doi: 10.1038/bjc.1998.54. Br J Cancer. 1998. PMID: 9461009 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

529 results

Search Page

Filters